PriceTargets.com logo

Redcare Pharmacy - SAEYY Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$8.85 As of 12/3/2025 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for SAEYY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Redcare Pharmacy Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SAEYY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SAEYY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Redcare Pharmacy in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $8.85.

This chart shows the closing price for SAEYY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in Redcare Pharmacy. This rating has held steady since May 2024, when it changed from a Reduce consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/11/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/10/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/8/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/6/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/7/2025BarclaysInitiated CoverageOverweight
6/9/2023HSBCDowngradeHold ➝ Reduce
5/23/2023Morgan StanleyUpgradeUnderweight ➝ Equal Weight
2/9/2023Credit Suisse GroupDowngradeOutperform ➝ Underperform
11/2/2022Morgan StanleyLower TargetUnderweight ➝ Underweight€34.00 ➝ €32.00
10/18/2022Morgan StanleyInitiated CoverageUnderweight
8/9/2022BarclaysLower TargetOverweight ➝ Overweight€135.00 ➝ €104.00
6/7/2022BarclaysLower Target€138.00 ➝ €136.00
6/6/2022Deutsche Bank AktiengesellschaftLower TargetBuy ➝ Buy€175.00 ➝ €160.00
5/12/2022Baader BankUpgradeBuy€110.00
5/10/2022BarclaysInitiated CoverageOverweight
1/11/2022HSBCInitiated CoverageHold
11/30/2021Credit Suisse GroupInitiated CoverageOutperform
10/4/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
7/21/2021Jefferies Financial GroupUpgradeHold ➝ Buy
7/14/2021BarclaysReiterated RatingOverweight
7/8/2021Berenberg BankReiterated RatingBuy
7/7/2021CitigroupReiterated RatingBuy
7/7/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
5/10/2021Berenberg BankReiterated RatingBuy
5/7/2021BarclaysReiterated RatingOverweight
3/23/2021Morgan StanleyInitiated CoverageOverweight
3/10/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
3/4/2021Berenberg BankReiterated RatingBuy
1/21/2021Berenberg BankReiterated RatingBuy
1/12/2021Jefferies Financial GroupDowngradeBuy ➝ Hold
1/12/2021BarclaysReiterated RatingOverweight
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/9/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/8/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/6/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Redcare Pharmacy logo
Redcare Pharmacy NV operates in online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It provides prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is headquartered in Sevenum, the Netherlands.
Read More

Today's Range

Now: $8.85
Low: $8.85
High: $8.85

50 Day Range

MA: $8.91
Low: $6.86
High: $12.15

52 Week Range

Now: $8.85
Low: $6.86
High: $16.60

Volume

N/A

Average Volume

818 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Redcare Pharmacy?

The following Wall Street research analysts have issued stock ratings on Redcare Pharmacy in the last year: Barclays PLC.
View the latest analyst ratings for SAEYY.

What is the current price target for Redcare Pharmacy?

0 Wall Street analysts have set twelve-month price targets for Redcare Pharmacy in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Redcare Pharmacy in the next year.
View the latest price targets for SAEYY.

What is the current consensus analyst rating for Redcare Pharmacy?

Redcare Pharmacy currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SAEYY will outperform the market and that investors should add to their positions of Redcare Pharmacy.
View the latest ratings for SAEYY.

What other companies compete with Redcare Pharmacy?

Other companies that are similar to Redcare Pharmacy include Alibaba Health Information Technology, Allstar Health Brands, Clicks Group, DocMorris and Fire & Flower. Learn More about companies similar to Redcare Pharmacy.

How do I contact Redcare Pharmacy's investor relations team?

Redcare Pharmacy's physical mailing address is Dirk Hartogweg 14, Venlo, Limburg 5928 LV. The company's listed phone number is 800-200-800-300. The official website for Redcare Pharmacy is shop-apotheke-europe.com. Learn More about contacing Redcare Pharmacy investor relations.